The Clorox Company (NYSE:CLX) Holdings Lifted by Venturi Wealth Management LLC

Venturi Wealth Management LLC boosted its position in shares of The Clorox Company (NYSE:CLX) by 380.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 360 shares of the company’s stock after buying an additional 285 shares during the quarter. Venturi Wealth Management LLC’s holdings in Clorox were worth $58,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Brooklyn Investment Group boosted its stake in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new position in Clorox during the third quarter valued at about $27,000. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares during the last quarter. Asset Planning Inc purchased a new stake in shares of Clorox during the fourth quarter valued at $32,000. Finally, Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox during the third quarter valued at $54,000. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Wells Fargo & Company upped their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Barclays upped their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Evercore ISI increased their price objective on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, DA Davidson cut their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Stock Performance

Shares of NYSE CLX opened at $154.52 on Tuesday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market cap of $19.03 billion, a price-to-earnings ratio of 42.22, a P/E/G ratio of 2.62 and a beta of 0.42. The business’s 50-day simple moving average is $157.53 and its 200-day simple moving average is $160.03. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the business posted $2.16 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.